$11.950
+0.632 (+5.29%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
FDMT-Prognose durch Analyse ähnlicher Charts
Alphio's FDMT stock price prediction model matches the current 4D Molecular Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.88 (-0.60%). The 1-week path is $11.63 (-2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich 4D Molecular Therapeutics Inc-Aktien kaufen?
Currently, 4D Molecular Therapeutics Inc is not a strong buy due to its low RSI of 37.91, indicating potential oversold conditions, and a forward P/E ratio of 0, suggesting uncertainty in future earnings. However, the stock has shown a year-to-date change of +55.05%, indicating strong performance this year. The main risk is the significant net income loss reported in the latest quarter, amounting to -68.76 million USD, which raises concerns about the company's profitability moving forward.
FDMT schloss am Tuesday bei $11.95, nachdem der Kurs +5.29% gestiegen ist
4D Molecular Therapeutics Inc (FDMT) last closed at $11.9499998, gaining +5.29%. These facts feed the 1-day and 1-week FDMT price prediction above.
Prognose-Treiber
Die Prognose-Treiber von 4D Molecular Therapeutics Inc (FDMT) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf FDMT am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für FDMT
Historically the probability of a positive November return for FDMT is 51.22%. February offers the highest probability of a positive month at 72.41%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.